X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Piramal Healthcare with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs GSK PHARMA - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES GSK PHARMA PIRAMAL ENTERPRISES/
GSK PHARMA
 
P/E (TTM) x 37.4 59.9 62.3% View Chart
P/BV x 3.7 11.8 31.7% View Chart
Dividend Yield % 0.7 2.1 31.1%  

Financials

 PIRAMAL ENTERPRISES   GSK PHARMA
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-16
GSK PHARMA
Mar-16
PIRAMAL ENTERPRISES/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0653,850 27.7%   
Low Rs8052,966 27.1%   
Sales per share (Unadj.) Rs383.0332.3 115.3%  
Earnings per share (Unadj.) Rs55.144.3 124.4%  
Cash flow per share (Unadj.) Rs74.147.2 156.8%  
Dividends per share (Unadj.) Rs17.5050.00 35.0%  
Dividend yield (eoy) %1.91.5 127.6%  
Book value per share (Unadj.) Rs719.9202.7 355.1%  
Shares outstanding (eoy) m172.5684.70 203.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.410.3 23.8%   
Avg P/E ratio x17.076.9 22.1%  
P/CF ratio (eoy) x12.672.2 17.5%  
Price / Book Value ratio x1.316.8 7.7%  
Dividend payout %31.8112.9 28.1%   
Avg Mkt Cap Rs m161,344288,643 55.9%   
No. of employees `0003.84.6 82.0%   
Total wages/salary Rs m16,8984,434 381.1%   
Avg. sales/employee Rs Th17,472.66,104.5 286.2%   
Avg. wages/employee Rs Th4,466.9961.6 464.5%   
Avg. net profit/employee Rs Th2,512.8813.7 308.8%   
INCOME DATA
Net Sales Rs m66,09928,148 234.8%  
Other income Rs m2,4251,218 199.0%   
Total revenues Rs m68,52429,366 233.3%   
Gross profit Rs m18,7234,774 392.2%  
Depreciation Rs m3,274248 1,320.3%   
Interest Rs m9,3880-   
Profit before tax Rs m8,4855,744 147.7%   
Minority Interest Rs m30-   
Prior Period Items Rs m1,5930-   
Extraordinary Inc (Exp) Rs m45726 1,756.5%   
Tax Rs m1,0322,018 51.1%   
Profit after tax Rs m9,5063,752 253.4%  
Gross profit margin %28.317.0 167.0%  
Effective tax rate %12.235.1 34.6%   
Net profit margin %14.413.3 107.9%  
BALANCE SHEET DATA
Current assets Rs m47,48821,462 221.3%   
Current liabilities Rs m104,36210,536 990.5%   
Net working cap to sales %-86.038.8 -221.7%  
Current ratio x0.52.0 22.3%  
Inventory Days Days4168 60.0%  
Debtors Days Days5116 311.6%  
Net fixed assets Rs m26,5324,717 562.5%   
Share capital Rs m345847 40.7%   
"Free" reserves Rs m114,02416,308 699.2%   
Net worth Rs m124,22117,171 723.4%   
Long term debt Rs m75,81216 473,825.0%   
Total assets Rs m308,35630,620 1,007.1%  
Interest coverage x1.9NM-  
Debt to equity ratio x0.60 65,498.2%  
Sales to assets ratio x0.20.9 23.3%   
Return on assets %6.112.3 50.0%  
Return on equity %7.721.9 35.0%  
Return on capital %10.033.6 29.7%  
Exports to sales %17.20 120,956.4%   
Imports to sales %6.615.1 43.9%   
Exports (fob) Rs m11,3624 284,037.5%   
Imports (cif) Rs m4,3644,237 103.0%   
Fx inflow Rs m14,435519 2,781.4%   
Fx outflow Rs m5,1838,320 62.3%   
Net fx Rs m9,253-7,801 -118.6%   
CASH FLOW
From Operations Rs m-67,7731,386 -4,891.3%  
From Investments Rs m-8,7685,010 -175.0%  
From Financial Activity Rs m76,199-6,383 -1,193.7%  
Net Cashflow Rs m-34212 -2,901.7%  

Share Holding

Indian Promoters % 52.9 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 4.0 10.2 39.2%  
FIIs % 26.6 23.8 111.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 15.4 107.1%  
Shareholders   93,274 102,036 91.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   SHASUN PHARMA  WYETH LTD  ASTRAZENECA PHARMA  ALEMBIC LTD  CIPLA  

Compare PIRAMAL ENTERPRISES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Red; Infosys Tanks as CEO Vishal Sikka Resigns(09:30 am)

Asian indices are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.2%, while the Hang Seng is down 0.7%. The Nikkei 225 is trading lower by 0.9%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Aug 18, 2017 10:35 AM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS